Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate and compound amino acids for prevention of postoperative acute kidney injury after cardiac surgery
ChiCTR2600132600Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in acute kidney failure (AKF) (4 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Incidence of postoperative acute kidney injury. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2600132600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132600.